June 16, 2026 | 11AM ET
In this free virtual event, leading CDMOs will break down how they support cell therapy programs from early process development through GMP manufacturing, scale‑up, tech transfer, and commercial readiness. You’ll learn where different approaches reduce downstream risk and where they can unintentionally create it.
Designed for CMC, Technical Operations, Process Development, Manufacturing, MSAT, Quality, Regulatory, Supply Chain, and Procurement teams, this event will help you evaluate CDMO partners with greater clarity and confidence.
Register now to gain practical insight into selecting the right cell therapy CDMO and strengthening your path from development to commercial success.
Offered Free by: Outsourced Pharma
See All Resources from: Outsourced Pharma
